Fosamax is leading to esophageal side effects

April 1996

Merck is busy putting out fires about reports that their new bone-building drug, Fosamax is leading to esophageal side effects.

Fosamax (alendronate) CAN irritate the esophageal mucosa. It's no surprise...in fact it's in the package labeling. But the severity of some cases seems to be worse than expected.

About 3 dozen patients have been hospitalized for severe esophageal irritation, erosions, and ulcerations.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote